ClinicalTrials.govpublic full text
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
chronic hepatitis b, hbeag positive, therapeutic hbv vaccine, hbv-specific cytotoxic t lymphocyte, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840099
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.